United States

LifeAssays AB (publ) (LIFEb.NGM)

LIFEb.NGM on Nordic Growth Market

21 Oct 2016
Change (% chg)

0.00kr (+6.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for LIFEb.NGM


LifeAssays publ AB is a Sweden-based diagnostic company. It is engaged in the provision of in-house diagnostic testing for community health centers and physicians, as well as for home use and veterinary applications. The Company develops and markets point-of-care testing (POCT) instruments and technology for the diagnosis of... (more)
No analyst recommendations are available for LIFEb.NGM.


Beta: 0.96
Market Cap(Mil.): kr77.85
Shares Outstanding(Mil.): 1,656.34
Dividend: --
Yield (%): --


  LIFEb.NGM Industry Sector
P/E (TTM): -- 42.81 36.35
EPS (TTM): -0.03 -- --
ROI: -69.84 7.54 13.88
ROE: -87.89 9.84 14.79

BRIEF-LifeAssays gets first order from new German distributor

* First order from new German distributor, Guder Medizintechnik GmbH Source text: http://bit.ly/2dcxV5N

Sep 27 2016

BRIEF-LifeAssays signs LoI with new distributor in Italy

* Signs letter of intent with new distributor in Italy, EosBio s.r.l. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 16 2016

BRIEF-LifeAssays signs distribution agreement for Germany

* Signs distribution agreement with Guder Medizintechnik GmbH

Sep 15 2016

BRIEF-LifeAssays Q2 operating loss widens to SEK 4.8 million

* Q2 net sales 2.2 million Swedish crowns ($260,000) versus 1.2 million crowns year ago

Aug 30 2016

BRIEF-Lifeassays raises SEK 4.1 million from exercise of warrants

* Company receives proceeds of 4.1 million Swedish crowns ($479,880)

Jul 07 2016

BRIEF-LifeAssays Q2 sales shows same positive trend as in Q1

* Sales in Q2 have shown same positive trend as in Q1 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 21 2016

BRIEF-LifeAssays Q1 net sales SEK 1.8 million

* Q1 operating loss 4.3 million crowns Source text for Eikon:

May 20 2016

BRIEF-LifeAssays units issue oversubscribed

* To raise proceeds of 19.3 million Swedish crowns ($2.40 million) before issue costs

Apr 29 2016

Earnings vs. Estimates

No consensus analysis data available.